Novus Therapeutics, Inc. 4
4 · Novus Therapeutics, Inc. · Filed May 26, 2017
Insider Transaction Report
Form 4
FLESHER GREGORY J.
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2017-05-24+250,000→ 250,000 totalExercise: $5.50Exp: 2027-05-23→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase a total of 250,000 shares of the Issuer's Common Stock. 150,000 shares will vest ratably each month over three years beginning on May 24, 2017 (the "grant date"). 100,000 shares will vest on the later of achievement of a performance-related goal or the first anniversary of the grant date.